Furthermore, the observed correlations between the expression levels of ESPL1/PTTG1 and PTTG1/PTTG1IP confirm the state of knowledge about the functional interaction of these proteins on a genetic level also for CML patients [28,37]. The gene discussed is PTTG1IP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.